Actualités et Activités de Aspira Women’s Health

Aspira Women’s Health est une société cotée sous le symbole boursier AWH (US).

Voir l'organigramme avec ses 16 principaux dirigeants

Biographies les plus recherchées chez Aspira Women’s Health

• Mike Buhle, Chief Executive Officer
• Jeffrey Cohen, Director
• Jack Fraser, Chairman of the Board

Changements de dirigeants chez Aspira Women’s Health

• John Strahley, a rejoint l'entreprise comme Chief Financial Officer  (publié le 31 mai 2026).

Créer une alerte
pour suivre les mouvements de dirigeants chez Aspira Women’s Health.

Aspira Women’s Health a 1 235 concurrents dont Thermo Fisher Scientific (Etats—Unis), Medtronic (Irlande) et Philips (Pays—Bas).

Actualités en fusion/acquisition en Équipements médicaux.

• Bridgepoint has announced the acquisition of Obagi Medical Products  (publié le 4 juin 2026).
• Niowave vient d'annoncer une levée de fonds de 70 millions de dollars. (publié le 2 juin 2026).
• Le nouveau nom de Edap Tms est FocalTherics. (publié le 1 juin 2026).

Contacts en Équipements médicaux

• Kweli Thompson - Executive Vice President and President, Neuroscience Portfolio chez Medtronic
• Ivan Tornos - Chairman, President and Chief Executive Officer chez Zimmer Biomet
• Jacob Thaysen - Chief Executive Officer and Director chez Illumina

En savoir plus sur le secteur Équipements médicaux

Derniers communiqués de presse par Aspira Women’s Health

• Aspira Women’s Health Successfully Reaches the First Milestone of the ARPA-H $10 Million Award – Aspira Women's Health
• Aspira Women’s Health Reports Selected Third Quarter 2024 Financial Results – Aspira Women's Health
• Aspira Women’s Health Reports Selected Third Quarter 2024 Financial Results – Aspira Women's Health
• Aspira Women’s Health Expands Co-Marketing and Distribution Collaboration with BioReference® to Include OvaWatch® – Aspira Women's Health
• Aspira Women’s Health to Announce Third Quarter Earnings Results and Host a Conference Call on Thursday, November 14, 2024 – Aspira Women's Health
• Aspira Women’s Health Selected to Receive $10 Million Award from ARPA-H’s Sprint for Women’s Health – Aspira Women's Health
• Aspira Women’s Health Issues Letter to Shareholders and Announces Virtual Research & Development Day on October 29, 2024 – Aspira Women's Health
• Aspira Women’s Health Receives Approval from New York State Department of Health for OvaWatch® – Aspira Women's Health
• Aspira Women’s Health Announces Publication of Data Demonstrating Performance of its In-Development Blood Test for the Assessment of Malignancy Risk in Patients with an Adnexal Mass – Aspira Women's Health
• Aspira Women’s Health to Present at the H.C. Wainwright 26th Annual Global Investment Conference – Aspira Women's Health
• Voir plus de communiqués de presse Close

Réseaux sociaux à propos de Aspira Women’s Health

• Aspira Women’s Health sur Wikipédia, Google News & Yahoo Finance en 1-click
• Aspira Women’s Health sur LinkedIn, X (Twitter) & YouTube en 1-click